Skip to content

Pediatric Cardiomyopathy Mutation Analysis

Pediatric Cardiomyopathy Mutation Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02432092
Enrollment
300
Registered
2015-05-01
Start date
2014-04-01
Completion date
2030-12-31
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathies, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Left Ventricular Non-compaction Cardiomyopathy, Restrictive Cardiomyopathy

Keywords

Cardiomegaly, Cardiovascular Diseases, Heart Diseases, Systolic dysfunction, Diastolic dysfunction, Ventricular hypertrophy, Heart failure

Brief summary

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

Detailed description

Cardiomyopathy is a genetically heterogeneous heart muscle disorder that results in ventricular dysfunction. While significant progress has been made in identifying the genetic basis of cardiomyopathy in adults, molecular diagnosis in children has proven more challenging and current algorithms do not incorporate mutation analysis in the clinical protocol. However, recent studies indicate that cardiomyopathy outcomes in children are origin specific, highlighting the importance of precise diagnosis. The goal of this study is to identify the genetic causes of pediatric cardiomyopathy. Rapid, comprehensive and cost-effective detection of genetic causes of cardiomyopathy will aid management and development of novel treatment strategies.

Interventions

None listed

Sponsors

Indiana University
Lead SponsorOTHER
American Heart Association
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects with cardiomyopathy * Family members of subjects with cardiomyopathy

Exclusion criteria

* Subjects without cardiomyopathy * Family members of subjects without cardiomyopathy

Design outcomes

Primary

MeasureTime frame
Elucidate the molecular genetics of cardiomyopathy7 years

Countries

United States

Contacts

CONTACTSarah Murphy, MPH
bankssk@iu.edu(317) 278-3026
CONTACTStephanie Ware, MD, PhD
stware@iu.edu(317) 278-2807
PRINCIPAL_INVESTIGATORStephanie Ware, MD, PhD

IU School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026